The Omnipod 5 Automated Insulin Delivery System is a tubeless and waterproof system that integrates with Dexcom continuous glucose monitors to automatically adjust insulin delivery based on real-time glucose readings. This approach effectively reduces the need for manual interventions such as multiple daily injections or fingerstick tests.
Clinical studies have demonstrated the effectiveness of the Omnipod 5 Automated Insulin Delivery System in improving glycemic control, with users experiencing lower A1C levels, increased time in the target glucose range, and reduced hypoglycemic episodes. The system is currently covered under public health plans in Ontario and Nova Scotia, with efforts underway to expand reimbursement to other provinces.
Image Credit: Insulet Corporation
